Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in lung cancer?

A S Teirstein1

  • 1Mount Sinai School of Medicine, New York 10029.

Environmental Research
|October 1, 1992
PubMed
Summary

Aggressive lung cancer treatments show minimal improvement over ten years. Prevention remains the most effective lung cancer control strategy, as emphasized by Selikoff.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide search for sarcoidosis susceptibility genes in African Americans.

Genes and immunity·2005
Same author

Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

American journal of respiratory and critical care medicine·2001
Same author

Clinical characteristics of patients in a case control study of sarcoidosis.

American journal of respiratory and critical care medicine·2001
Same author

Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine.

The Mount Sinai journal of medicine, New York·2001
Same author

Pulmonary complications in cardiac transplant recipients.

Chest·2001
Same author

Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy.

Chest·2001

Area of Science:

  • Oncology
  • Pulmonary Medicine
  • Epidemiology

Background:

  • Cigarette smoking and asbestos exposure are established causes of lung cancer.
  • Recent advancements in chemotherapy, radiotherapy, and surgery suggest improved lung cancer prognosis.
  • Early research highlighted the etiological significance of smoking and asbestos in lung cancer development.

Purpose of the Study:

  • To compare the treatment outcomes of non-small-cell lung cancer (NSCLC) patients over a ten-year period.
  • To evaluate the impact of combined surgical, chemotherapeutic, and radiotherapeutic interventions on NSCLC prognosis.

Main Methods:

  • A retrospective analysis comparing two cohorts of 100 NSCLC patients each.
  • Cohort 1: Patients diagnosed and treated between 1979-1980.
  • Cohort 2: Patients diagnosed and treated between 1989-1990, all referred to a pulmonary consultant.

Main Results:

  • Complete resectability rates were 28% in the earlier group and 38% in the later group.
  • Cancer cure rates showed a slight increase from 12% (1979-1980) to 25% (1989-1990) within a less than 2-year follow-up.
  • These improvements are expected to diminish over time, indicating limited long-term benefit.

Conclusions:

  • Current multimodal treatments for NSCLC have yielded minimal improvement in prognosis over the past decade.
  • The findings underscore the critical importance of cancer prevention strategies for effective lung cancer control.
  • Prevention, particularly addressing smoking and asbestos exposure, remains the most effective method for managing lung cancer, echoing Selikoff's emphasis.

Related Experiment Videos